TipRanks
MAUNA KEA TECHNOLOGIES (FR:ALMKT)
:ALMKT
Want to see FR:ALMKT full AI Analyst Report?

MAUNA KEA TECHNOLOGIES (ALMKT) Price & Analysis

1 Followers

ALMKT Stock Chart & Stats

€0.16
€0.00(0.00%)
At close: 4:00 PM EDT
€0.16
€0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Revenue ReboundThe sharp 2025 revenue recovery shows that demand for the company’s offering can return after a weak period. If this rebound develops into sustained adoption, it could improve operating leverage and provide a larger installed base for recurring consumables and service revenue.
Strong Gross MarginA gross margin near 75% indicates meaningful value capture from the company’s products and supports the economics of its platform and related consumables. Maintaining this level would provide resources to fund commercial expansion and offset some of the company’s substantial operating-cost burden.
Debt ReductionThe substantial reduction in debt lowers absolute repayment obligations and represents a constructive balance-sheet action. Although leverage remains problematic because equity is negative, continued deleveraging could reduce financial pressure and improve the company’s ability to allocate resources toward operations and growth.
Bears Say
Deep Operating LossesThe deeply negative operating margin shows that the core business is not yet covering its operating expenses, even when revenue and gross profit improve. This limits the durability of earnings and means future growth must be accompanied by significant cost discipline or greater scale to create operating profitability.
Persistent Cash BurnPersistent negative operating and free cash flow indicates that reported business activity is not currently funding the company’s ongoing needs. Continued cash burn can require external funding or balance-sheet actions, reducing financial flexibility and limiting the company’s ability to invest consistently without additional capital.
Negative Shareholders’ EquityNegative equity reflects accumulated deficits and leaves the company with limited balance-sheet protection against further losses. Even after debt reduction, this weak capital position can constrain financing choices, elevate solvency and refinancing risk, and make sustained investment in commercial development more difficult.

ALMKT FAQ

What was MAUNA KEA TECHNOLOGIES’s price range in the past 12 months?
MAUNA KEA TECHNOLOGIES lowest stock price was €0.07 and its highest was €0.23 in the past 12 months.
    What is MAUNA KEA TECHNOLOGIES’s market cap?
    MAUNA KEA TECHNOLOGIES’s market cap is €24.57M.
      When is MAUNA KEA TECHNOLOGIES’s upcoming earnings report date?
      MAUNA KEA TECHNOLOGIES’s upcoming earnings report date is Apr 22, 2027 which is in 194 days.
        How were MAUNA KEA TECHNOLOGIES’s earnings last quarter?
        MAUNA KEA TECHNOLOGIES released its earnings results on Oct 08, 2026. The company reported -€0.025 earnings per share for the quarter.
          Is MAUNA KEA TECHNOLOGIES overvalued?
          According to Wall Street analysts MAUNA KEA TECHNOLOGIES’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does MAUNA KEA TECHNOLOGIES pay dividends?
            MAUNA KEA TECHNOLOGIES does not currently pay dividends.
            What is MAUNA KEA TECHNOLOGIES’s EPS estimate?
            MAUNA KEA TECHNOLOGIES’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does MAUNA KEA TECHNOLOGIES have?
            MAUNA KEA TECHNOLOGIES has 195,260,220 shares outstanding.
              What happened to MAUNA KEA TECHNOLOGIES’s price movement after its last earnings report?
              MAUNA KEA TECHNOLOGIES reported an EPS of -€0.025 in its last earnings report. Following the earnings report the stock price went down -3.101%.
                Which hedge fund is a major shareholder of MAUNA KEA TECHNOLOGIES?
                Currently, no hedge funds are holding shares in FR:ALMKT
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  MAUNA KEA TECHNOLOGIES

                  Mauna Kea Technologies SA operates as a medical device enterprise, producing and distributing its offerings throughout Europe and worldwide. Its product line serves various medical specialties such as gastroenterology, pulmonology, and urology. Central to its portfolio is Cellvizio, an in vivo cellular imaging platform that delivers real-time data. This innovative system assists medical practitioners in tracking disease evolution, evaluating immediate physiological responses, delineating ambiguous tissue areas, and providing guidance during surgical procedures. Founded in 2000, the company's headquarters are situated in Paris, France.

                  MAUNA KEA TECHNOLOGIES (ALMKT) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Theraclion SA
                  ―
                  ―
                  Novacyt
                  ―
                  ―
                  Eurobio-Scientific SA
                  ―
                  ―
                  Ikonisys SA
                  ―
                  ―
                  Median Technologies
                  ―
                  ―
                  Popular Stocks